ADMA Biologics Competitors and Similar CompaniesClear all
CorMedix's competitors and similar companies include Array BioPharma.
 CorMedix CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease. |  Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | |
Founding Date | Founding Date 2006 | Founding Date 1998 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Berkeley Heights, US HQ | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US |
Employees | Employees 3036% increase | Employees 110 |
Financial | ||
Revenue (est.) | Revenue (est.) $311.7m (FY, 2025) | Revenue (est.) $173.8m (FY, 2018) |
Cost of goods | Cost of goods $22.1m (FY, 2025) | Cost of goods $59.4m (FY, 2018) |
Gross profit | Gross profit $275.7m (FY, 2025) | Gross profit $114.4m (FY, 2018) |
Net income | Net income $163.1m (FY, 2025) | Net income ($147.7m) (FY, 2018) |
For sources of this data, please see the company profile
View Company Profiles
Array BioPharma
HQ
Boulder, US
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View company